Discover
AXSM
Axsome Therapeutics, Inc.
168.35
2 x 170.52
2 x 259.20
bid
ask
-
1.73
1.02%
2 @ 04:01 PM
168.52 +0.17 (0.10%)
| Ytd | -7.82% | |
| 1y | 37.41% |
166.12
day range
170.64
121.15
52 week range
255.17
| Open | 168.53 | Prev Close | 170.08 | Low | 166.12 | High | 170.64 | Mkt Cap | 8.82B |
| Vol | 894.52K | Avg Vol | 712.30K | EPS | -3.70 | P/E | N/A | Forward P/E | 35.80 |
| Beta | 0.85 | Short Ratio | 5.48 | Inst. Own | 74.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 204.48 | 200-d Avg | 200.29 | 1yr Est | 284.63 |
| Income Statement | |||
| Total Revenue | 218.38M | ||
| Revenues (USD) | 218.38M | ||
| Cost of Revenue | 13.56M | ||
| Gross Profit | 204.81M | ||
| Operating Expenses | 254.46M | ||
| Research and Development Expense | 46.23M | ||
| Selling, General and Administrative Expense | 208.14M | ||
| Operating Income | -49.65M | ||
| Interest Expense | 1.54M | ||
| Income Tax Expense | 128.00K | ||
| Net Income | -51.31M | ||
| Net Income Common Stock | -51.31M | ||
| Net Income Common Stock (USD) | -51.31M | ||
| Consolidated Income | -51.31M | ||
| Earnings per Basic Share | -0.99 | ||
| Earnings per Basic Share (USD) | -0.99 | ||
| Earnings per Diluted Share | -0.99 | ||
| Earning Before Interest & Taxes (EBIT) | -49.65M | ||
| Earning Before Interest & Taxes (USD) | -49.65M | ||
| Weighted Average Shares | 51.80M | ||
| Weighted Average Shares Diluted | 51.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 319.85M | ||
| Cash and Equivalents (USD) | 319.85M | ||
| Trade and Non-Trade Receivables | 277.46M | ||
| Current Assets | 656.57M | ||
| Property, Plant & Equipment Net | 20.03M | ||
| Total Assets | 761.45M | ||
| Debt Current | 70.65M | ||
| Total Debt | 219.21M | ||
| Current Liabilities | 460.45M | ||
| Debt Non-Current | 148.56M | ||
| Total Liabilities | 678.14M | ||
| Accumulated Retained Earnings (Deficit) | -1.42B | ||
| Shareholders Equity | 83.30M | ||
| Shareholders Equity (USD) | 83.30M | ||
| Assets Non-Current | 104.88M | ||
| Total Debt (USD) | 219.21M | ||
| Goodwill and Intangible Assets | 49.40M | ||
| Inventory | 37.88M | ||
| Liabilities Non-Current | 217.70M | ||
| Trade and Non-Trade Payables | 78.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.74M | ||
| Net Cash Flow from Financing | 48.15M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 14.74M | ||
| Capital Expenditure | -450.00K | ||
| Issuance (Purchase) of Equity Shares | 55.44M | ||
| Issuance (Repayment) of Debt Securities | -1.21M | ||
| Net Cash Flow from Investing | -450.00K | ||
| Net Cash Flow from Operations | -32.95M | ||
| Share Based Compensation | 27.15M | ||